Participants:18–64 years · 65+ years
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study of Durvalumab, Tremelimumab, and Bevacizumab for Patients with Non-Resectable Liver Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Plasma cell myeloma+1

Not recruiting

Registered drugNo placebo

Study Comparing bb2121 with Standard Treatments for Patients with Relapsed and Refractory Multiple Myeloma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study of Pirtobrutinib, Venetoclax and Rituximab combination compared to Venetoclax and Rituximab in previously treated Chronic Lymphocytic Leukemia patients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Pirtobrutinib

Contact Research Centre

Parkinson's disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of BIIB122 for Patients with Parkinson's Disease

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:N2-(3-(2-(2H-1,2,3-Triazol-2-Yl)Propan-2-Yl)-1-Cyclopropyl-1H-Pyrazol-5-Yl)-N4-Ethyl-5-(Trifluoromethyl)Pyrimidine-2,4-Diamine

Contact Research Centre

Herpes simplex

Not recruiting

Registered drugNo placebo

Study on Pritelivir for Treating Acyclovir-Resistant Herpes Simplex Virus in Immunocompromised Patients

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Anhydrous Cidofovir

Contact Research Centre

Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Secukinumab

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

InvestigationalNo placebo

Study on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Seralutinib

Contact Research Centre

Systemic candida

Not recruiting

Registered drug

Study Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Anidulafungin

Contact Research Centre

Chronic myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Nilotinib

Contact Research Centre

Neoplasm malignant

Not recruiting

Registered drugNo placebo

Study on the Safety and Anti-tumor Effects of GEN1042 Alone or with Pembrolizumab and Chemotherapy in Patients with Advanced Solid Tumors

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Find therapies in clinical trials near you – page 30

446 trials match your criteria

Non-small cell lung cancer

Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

Study on the Safety and Immune Response of RSVPreF3 Vaccine for Respiratory Syncytial Virus in Adults Aged 60 and Above

Study on the Safety and Immune Response of RSVPreF3 Vaccine for Respiratory Syncytial Virus in Adults Aged 60 and Above

Hepatocellular carcinoma

Study of Durvalumab, Tremelimumab, and Bevacizumab for Patients with Non-Resectable Liver Cancer

Plasma cell myeloma+1

Study Comparing bb2121 with Standard Treatments for Patients with Relapsed and Refractory Multiple Myeloma

Chronic lymphocytic leukaemia

Study of Pirtobrutinib, Venetoclax and Rituximab combination compared to Venetoclax and Rituximab in previously treated Chronic Lymphocytic Leukemia patients

Parkinson's disease

Study on the Effectiveness and Safety of BIIB122 for Patients with Parkinson's Disease

Herpes simplex

Study on Pritelivir for Treating Acyclovir-Resistant Herpes Simplex Virus in Immunocompromised Patients

Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

Pulmonary arterial hypertension

Study on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension

Systemic candida

Study Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients

Chronic myeloid leukaemia

Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Neoplasm malignant

Study on the Safety and Anti-tumor Effects of GEN1042 Alone or with Pembrolizumab and Chemotherapy in Patients with Advanced Solid Tumors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.